首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

北美臨床試驗市場預測至 2028 年 - 區域分析 - 按研究設計、階段和適應症

市場調查報告書

商品編碼

1402477

北美臨床試驗市場預測至 2028 年 - 區域分析 - 按研究設計、階段和適應症

North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design, Phase, and Indication

出版日期: 2023年10月26日 | 出版商:

The Insight Partners | 英文 132 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美臨床試驗市場預計將從2022年的273.2228億美元成長到2028年的3,681,815萬美元。預計2022年至2028年CAGR為5.1%。

醫藥產業的蓬勃發展和醫藥產業研發活動的增加推動北美臨床試驗市場

製藥業是全球研發最密集的產業之一。隨著製藥公司熱衷於確保研發實現其預期目標，藥品的價值變得越來越重要。在過去十年中，每年批准的新藥數量也有所增加。我們正在努力提高滿足患者需求的有效性和效率。美國是研發投資的領先國家，在過去十年中生產了世界上一半以上的新分子。美國佔 2014-2019 年新上市新藥銷售額的 62.3%。研發是製藥公司業務的重要組成部分，因為它使製藥公司能夠為各種治療應用開發出具有巨大醫療和商業潛力的新分子。

研發支出用於發現、檢驗和生產新產品；預付款；改善現有成果；並在推出前證明產品功效和法規合規性。研發投資依臨床試驗的需要和要求而有所不同。成本包括材料、使用的用品和工資，以及開發品質控制的成本。

北美臨床試驗市場概況

北美臨床試驗市場分為美國、加拿大和墨西哥。美國是最大且成長最快的臨床試驗市場。該地區的市場成長歸功於美國作為領先的臨床研究目的地以及公司為臨床試驗應用提供的創新服務。

美國已成為領先的臨床研究目的地。近一半的臨床試驗是在美國進行的。此外，由於成熟的醫療基礎設施、快速的核准時間表、有利的監管框架以及全球公認的臨床試驗產生資料，大多數製藥研究公司更願意在美國進行臨床試驗。世界衛生組織 (WHO) 報告指出，美國 2021 年登記的臨床試驗數量最多（157,618 項）。

北美臨床試驗市場收入及 2028 年預測（百萬美元）

北美臨床試驗市場細分

北美臨床試驗市場分為階段、研究設計、適應症和國家。

根據階段，北美臨床試驗市場分為 I 期、II 期、III 期和 IV 期。 2022 年，III 期臨床試驗市佔率佔北美最大市場。

根據研究設計，北美臨床試驗市場分為介入性、觀察性和擴展性。 2022 年，介入性細分市場佔據北美最大的臨床試驗市場。

根據適應症，北美臨床試驗市場分為自體免疫/發炎、疼痛管理、腫瘤、中樞神經系統疾病、糖尿病、肥胖、心血管等。 2022 年，腫瘤學領域佔據北美最大的臨床試驗市場。

依國家分類，北美臨床試驗市場分為美國、加拿大和墨西哥。 2022年，美國在北美臨床試驗市場佔有率中佔據主導地位。

Charles River Laboratories International Inc、ICON Plc、IQVIA Holdings Inc、IXICO Plc、Laboratory Corp of America Holdings、Parexel International Corp、SGS SA、Syneos Health Inc、Thermo Fisher Scientific Inc 和 WuXi AppTec Co Ltd. 都是領先公司業務遍及北美北美臨床試驗市場。

The pharmaceutical industry is one of the most R&D-intensive industries globally. The value of medicines is becoming increasingly important as pharmaceutical companies are keen to ensure that R&D achieves their intended goal. Over the last decade, the number of new drugs approved yearly has also increased. Efforts are being made to achieve greater effectiveness and efficiency in fulfilling patients' needs. The US is a leading country in R&D investments, producing over half of the world's new molecules in the past decade. The US accounted for 62.3% of sales of new medicines launched during 2014-2019. R&D is a significant and essential part of the business of pharmaceutical companies as it enables them to come up with new molecules for various therapeutic applications with significant medical and commercial potential.

R&D expenditure is done to discover, examine, and produce new products; upfront payments; improve existing outcomes; and demonstrate product efficacy and regulatory compliance before launch. The R&D investments differ as per the need and demand for clinical trials. The cost includes materials, supplies used, and salaries, along with the cost of developing quality control.

North America Clinical Trials Market Overview

The North America clinical trials market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trials. The market growth in the region is accredited to the US emerging as a leading clinical research destination and the innovative services offered by companies for applications in clinical trials.

The US has emerged as a leading clinical research destination. Nearly half of the total clinical trials are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial generated data globally. A World Health Organization (WHO) report states that the US registered the highest number of clinical trials (157,618) in 2021.

North America clinical Trials Market Revenue and Forecast to 2028 (US$ Million)

North America Clinical Trials Market Segmentation

The North America clinical trials market is segmented into phase, study design, indication, and country.

Based on phase, the North America clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest North America clinical trials market share in 2022.

Based on study design, the North America clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest North America clinical trials market share in 2022.

Based on Indication, the North America clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest North America clinical trials market share in 2022.

Based on country, the North America clinical trials market has been categorized into the US, Canada, and Mexico. The US dominated the North America clinical trials market share in 2022.

Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, IXICO Plc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, Thermo Fisher Scientific Inc, and WuXi AppTec Co Ltd. are some of the leading companies operating in the North America clinical trials market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America clinical trials market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America clinical trials market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the clinical trials market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Clinical Trials Market - By Phase
- 1.3.2 North America Clinical Trials Market - By Study Design
- 1.3.3 North America Clinical Trials Market - By Indication
- 1.3.4 North America Clinical Trials Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Clinical Trials Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
4.3 Experts Opinion

5. North America Clinical Trials Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
- 5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
- 5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. Clinical Trials Market - North America Analysis

6.1 North America Clinical Trials Market Revenue Forecast and Analysis

7. North America Clinical Trials Market Revenue and Forecast To 2028 - by Study Design

7.1 Overview
7.2 North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
- 7.3.1 Overview
- 7.3.2 Interventional: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
- 7.4.1 Overview
- 7.4.2 Observational: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
- 7.5.1 Overview
- 7.5.2 Expanded Access: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Clinical Trials Market - By Phase

8.1 Overview
8.2 North America Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
- 8.3.1 Overview
- 8.3.2 Phase III: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
- 8.4.1 Overview
- 8.4.2 Phase II: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
- 8.5.1 Overview
- 8.5.2 Phase IV: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
- 8.6.1 Overview
- 8.6.2 Phase I: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Clinical Trials Market Revenue and Forecast To 2028 - Indication

9.1 Overview
9.2 North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
- 9.3.1 Overview
- 9.3.2 Autoimmune/Inflammation: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
- 9.4.1 Overview
- 9.4.2 Pain Management: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
- 9.5.1 Overview
- 9.5.2 Oncology: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
- 9.6.1 Overview
- 9.6.2 CNS Condition: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
- 9.7.1 Overview
- 9.7.2 Diabetes: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
- 9.8.1 Overview
- 9.8.2 Obesity: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
- 9.9.1 Overview
- 9.9.2 Cardiovascular: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Other
- 9.10.1 Overview
- 9.10.2 Other: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Clinical Trials Market - Revenue and Forecast to 2028 - Country Analysis

10.1 North America: Clinical Trials Market
- 10.1.1 Overview
- 10.1.2 North America: Clinical Trials Market, by Country, 2022& 2028 (%)
  - 10.1.2.1 US: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 US: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.1.4 US: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.1.5 US: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.2 Canada: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 Canada: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.2.4 Canada: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.2.5 Canada: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.3 Mexico: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Mexico: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 Mexico: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.3.4 Mexico: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.3.5 Mexico: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 IQVIA Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Parexel International Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 IXICO Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 ICON Plc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 WuXi AppTec Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 SGS SA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Syneos Health Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Laboratory Corp of America Holdings
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. US Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms

List Of Figures

Figure 1. North America Clinical Trials Market Segmentation
Figure 2. North America Clinical Trials Market, By Country
Figure 3. North America Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in North America Clinical Trials Market
Figure 5. Canada is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Experts Opinion
Figure 8. Impact Analysis
Figure 9. North America Clinical Trials Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Clinical Trials Market, by Key Country - Revenue (2022) (US$ Million)
Figure 29. North America: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. US: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Canada: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Mexico: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Growth Strategies Done by the Companies in the Market, (%)